USA-USFDACVM-2025-US-075364
Received 2025-12-29 · MSK · MSK
- Species
- Cat
- Breed
- Cat (other)
- Sex
- Male Unknown
- Region
- USA
- Reactions
- General illnessUnable to walk
- Body systems
- Other
- Outcomes
- Outcome Unknown
Roxee Medication Guide
Frunevetmab
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Both
Reference complete
FDA data linked
Sources vary
Rx required
Injection
Zoetis Inc.
Official label facts
Owner quick guide first
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Source variance noted.
Roxee found source differences in non-clinical fields such as brand, manufacturer, source URL, or display metadata. Core owner guidance and official source links are still available.
Source variance fields
- Dosage forms (Official label describes Solensia as frunevetmab injection.)
Data freshness
Reference facts
Reference refreshed
Jun 22, 2026, 10:47 a.m.
These are the reference facts Roxee uses on browse cards and quick facts.
FDA applications
FDA application data refreshed
Jun 22, 2026, 10:41 a.m.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
Safety reports
Safety data refreshed
Jun 22, 2026, 10:42 a.m.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
Source timing details
-
Reference facts:
Source Roxee
| Refreshed Jun 22, 2026, 10:47 AM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Jun 22, 2026, 10:40 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed May 15, 2026, 10:00 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Jun 22, 2026, 10:41 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Image coming soon
Frunevetmab
Frunevetmab
Drug type: Generic ingredient • Branded profile • FDA branded products available
Both
Injection
Rx required
100% reference complete
Species: Both
Manufacturer: Zoetis Inc.
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Frunevetmab
For the control of pain associated with osteoarthritis in cats. Species commonly shown: Cats.
Generic name
Frunevetmab
Brand names
Solensia™, Solensia
Medication class
branded
Manufacturer
Zoetis Inc.
Species
Cat
Dosage forms
Injection
Strengths
7 mg/mL
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Solensia™
Solensia
Dosage forms
Injection
Strengths
7 mg/mL
Indications / Uses
For the control of pain associated with osteoarthritis in cats.
Administration / How To Give
Administer by subcutaneous injection once a month, dosed by weight range, as directed and given by a veterinarian.
Warnings / Contraindications
Do not administer Solensia to cats with known hypersensitivity to frunevetmab.
- Do not administer Solensia to cats with known hypersensitivity to frunevetmab; accidental self-injection can cause hypersensitivity reactions in people.
Side Effects
Top reported reactions (openFDA): General illness, Lethargy (see also Central nervous system depression in Neurological), Prescribing error, Anorexia, Behavioural disorder NOS, Confusion.
FAQ
Cats
Yes. Roxee shows this as prescription-only.
Injection, Injectable Solution
Related Conditions
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
- Verified source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a73b79c4-3623-4b52-81ea-6180528a031e
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.roxee.ai/conditions/
- Last refreshed: Jun 22, 2026, 10:47 a.m.
- Last verified: May 15, 2026, 10:04 a.m.
- Validation status: Complete
Add to My Pet's Medications
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continuePet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Used for:
For the control of pain associated with osteoarthritis in cats.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- wobbly/unsteady walking (1 reports)
- Hair loss (1 reports)
- Congestive heart failure (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Research brief
Medication Research Insights
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
What to know
Evidence-backed context
Limited
Roxee has limited cited overview evidence for Frunevetmab; use the official documents and your veterinarian's instructions for product-specific decisions.
Source: openFDA case USA-USFDACVM-2025-US-069686
Safety signal coverage
Reported signals
32 tracked reaction signals; 32 reported cases; 28 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Source: openFDA case USA-USFDACVM-2025-US-069686
Interpretation guardrail
Not causation
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Evidence tension
Stronger signal
Label / review
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Source: openFDA case USA-USFDACVM-2025-US-069686
Weaker signal
Reported data
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Reaction signal map
Most reported reactions
Top terms
Unsteady walking (ataxia) (1 reports), Hair loss (1 reports), Congestive heart failure (1 reports), Confusion (1 reports), Collapse NOS (1 reports)
Body systems represented
Signal grouping
Digestive (2), Skin & allergy (4), Neurologic (1), Behavior (1)
Species and breed lens
Species represented in reports
Species lens
Cat (30 reports), Dog (2 reports)
Breed metadata in reports
Metadata only
Domestic Shorthair (3), Cat (other) (2), Domestic Longhair (1), Persian (1). These are report metadata, not proof that a breed is at higher risk.
What your vet may verify
Fit for this patient
Vet check
Verify whether Frunevetmab fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Evidence limitations
Evidence review
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
What to watch next
Watch list
Owner-safe
wobbly/unsteady walking, Hair loss, Congestive heart failure
Call sooner if
Escalation
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Bottom line: Use this Frunevetmab brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
- openFDA case USA-USFDACVM-2025-US-069686 · adverse_reaction · adverse reactions
- Contraindication and user safety warning from the official Solensia label. · safety_warning · warnings contraindications
- FDA application profile · official_label · quick facts
- Medication usage source · fda_animal_drugs · quick facts
- FOI · document · documents
- SPL · document · documents
- Safety communication · document · documents
- Official label · document · documents
Evidence
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: May 15, 2026, 10:04 AM UTC
Sources:
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Contraindication and user safety warning from the official Solensia label. · safety_warning
- openFDA case USA-USFDACVM-2025-US-069686 · adverse_reaction
- FOI · document
Safety & side effects
Side effects to monitor:
- wobbly/unsteady walking
- Hair loss
- Congestive heart failure
Most reported reactions:
- Unsteady walking (ataxia) (1 reports)
- Hair loss (1 reports)
- Congestive heart failure (1 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Vet Fast Scan
Source-backed clinical checkpoints for quick review.
FDA-labeled species
Cat
Indication / use
For the control of pain associated with osteoarthritis in cats.
Form / route / dose
Form: Injectable Solution
Route: Subcutaneous
Confirm product label and patient-specific plan.
Route: Subcutaneous
Confirm product label and patient-specific plan.
Warnings
No structured warnings linked yet.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
- FDA Osteoarthritis in Cats Official label / PI
- Solensia Official Label (DailyMed) Official label / PI
- Solensia™ SPL
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Zoetis Inc.
Form: Injectable Solution
Identifiers:
NADA: 141546
NDC Package: 54771-3520-1
NDC Package: 54771-3520-2
NDC Product: 54771
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141546 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Reported case explorer
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
37
Matching reports
35
Active filters
1
Selected filters
Body system: Other
Clear
Drill into common report signals
Showing up to 50 matching reports.
USA-USFDACVM-2025-US-075203
Received 2025-12-29 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- 10-24 lb (4.853 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Miliary dermatitisSkin scabPruritusAbnormal cytologyPyodermaPartial lack of efficacySkin lesion NOSCrustSkin sore
- Body systems
- OtherSkin & allergyEffectiveness
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-075165
Received 2025-12-29 · MSK · MSK
- Species
- Cat
- Breed
- Persian
- Size / weight
- Under 10 lb (4.4 Kilogram)
- Age
- 8+ years (12.5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Intentional misuseLack of efficacy - NOSDeath by euthanasiaGait abnormalityLumbar pain
- Body systems
- OtherEffectiveness
- Outcomes
- Euthanized
USA-USFDACVM-2025-US-075411
Received 2025-12-24 · MSK · MSK
- Species
- Cat
- Breed
- Cat (other)
- Age
- 8+ years (12 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Congestive heart failureDeath
- Body systems
- Other
- Outcomes
- Died
USA-USFDACVM-2025-US-075300
Received 2025-12-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (9.072 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- VomitingHidingDazedHeavy breathingDeath
- Body systems
- DigestiveOther
- Outcomes
- Died
USA-USFDACVM-2025-US-075219
Received 2025-12-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- 10-24 lb (7.711 Kilogram)
- Age
- 8+ years (15 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- DermatitisHyperpigmentation
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-075455
Received 2025-12-22 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (4.754 Kilogram)
- Age
- 8+ years (11 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Miliary dermatitisExcoriation
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-074332
Received 2025-12-17 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.876 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- FeverNot eatingNeutrophiliaMonocytosisImmune mediated haemolytic anaemiaBehavioural disorder NOSDecreased haematocrit
- Body systems
- OtherBehavior
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073852
Received 2025-12-17 · MSK · MSK
- Species
- Cat
- Breed
- ['Cat (unknown)', 'Cat (unknown)']
- Size / weight
- Under 10 lb (3.58 Kilogram)
- Age
- 8+ years (17 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- VomitingCollapse NOS (see also Cardio-vascular and Neurological disorders)Decreased haematocrit
- Body systems
- DigestiveNeurologicOther
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-074273
Received 2025-12-16 · MSK · MSK
- Species
- Cat
- Breed
- Maine Coon
- Size / weight
- 10-24 lb (4.59 Kilogram)
- Age
- 8+ years (19 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Chewing - pruritus (see also Oral cavity disorders)Peripheral neuropathy
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-074107
Received 2025-12-16 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (4.296 Kilogram)
- Age
- 8+ years (11 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- PruritusAlopecia NOSSkin lesion NOSDermatitis
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072694
Received 2025-12-15 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- 10-24 lb (5.05 Kilogram)
- Age
- 8+ years (11 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- CrustAbrasionSkin irritationAlopecia localLocal erythemaSkin ulcerSkin scab
- Body systems
- OtherSkin & allergy
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072860
Received 2025-12-12 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (4.128 Kilogram)
- Age
- 8+ years (16 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Seizure NOSWobblinessInappropriate elimination NOSVocalisationDistressBehavioural disorder NOSHead twitchingEye disorder NOS (for Photophobia see neurological)ConfusionAbnormal movement NOS
- Body systems
- NeurologicOtherBehaviorSkin & allergy
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072888
Received 2025-12-11 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- 10-24 lb (5.715 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- SyncopeCollapse NOS (see also Cardio-vascular and Neurological disorders)AnorexiaHidingLow blood pressureHepatomegalyHepato-biliary disorder NOSIntentional misuse
- Body systems
- OtherNeurologicDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073134
Received 2025-12-10 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (9.172 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)Decreased appetiteInjection site lumpInjection site bleedingWoundInjection site complication NOS
- Body systems
- NeurologicDigestiveOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073108
Received 2025-12-10 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.901 Kilogram)
- Age
- 8+ years (15 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Local erythemaSkin ulcerExudative skin conditionSkin lesion NOS
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-073128
Received 2025-12-05 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- 10-24 lb (4.536 Kilogram)
- Age
- 8+ years (17 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Medication error NOSSkin lesion NOSDermatitisVomiting
- Body systems
- OtherDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-071549
Received 2025-12-03 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (9.253 Kilogram)
- Age
- 8+ years (15 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Joint swellingPain NOS
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-071903
Received 2025-12-02 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (4.99 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Injection site hair lossPapuleInjection site itching
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-071810
Received 2025-12-02 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (5.761 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Breathing difficultyWheezingSneezing
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-071470
Received 2025-12-02 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (5.761 Kilogram)
- Age
- 8+ years (16 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- DiarrhoeaGait abnormalityVocalisation
- Body systems
- DigestiveOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-075182
Received 2025-11-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (4.76 Kilogram)
- Age
- 8+ years (11 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Cold feeling to the touchDecreased appetiteLack of efficacy - NOSBehavioural disorder NOSVomitingRenal disorder NOSLethargy (see also Central nervous system depression in Neurological)Elevated renal parametersArthritisReluctant to moveWeight gainWobblinessDental diseaseRespiratory tract infection NOSAnaemia NOSElevated creatinineHypercalcaemiaFeverDehydrationDiarrhoeaDecreased haematocritDecreased red blood cell countDigestive tract disorder NOSSicknessDistressDiabetesDecreased body temperatureDeath by euthanasia
- Body systems
- OtherDigestiveEffectivenessBehaviorNeurologic
- Outcomes
- Euthanized
USA-USFDACVM-2025-US-069596
Received 2025-11-24 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (6.2 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Not eatingVomitingCardiac enlargementSplenomegalyAbnormal ultrasound findingHaematuriaPyuriaNon-regenerative anaemiaDecreased haematocritHypokalaemiaBladder distensionDehydrationElevated creatinineNot urinatingIntentional misuseUrinary tract disorder NOS
- Body systems
- OtherDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069160
Received 2025-11-20 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.629 Kilogram)
- Age
- 8+ years (12 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Excessive chewing, licking and/or groomingSkin lesion NOSHot spot (pyotraumatic dermatitis)
- Body systems
- Other
- Outcomes
- Recovered/Normal
USA-USFDACVM-2025-US-069277
Received 2025-11-19 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.5 Kilogram)
- Age
- 8+ years (16 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Joint swellingBone and joint disorder NOSAbnormal radiograph findingPolyarthropathy NOS (see also PT Immune-mediated polyarthropathy)
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069108
Received 2025-11-19 · MSK · MSK
- Species
- Cat
- Breed
- Cat (other)
- Size / weight
- 10-24 lb (5.352 Kilogram)
- Age
- 8+ years (9 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Skin lesion NOSFacial pruritusAlopecia
- Body systems
- OtherSkin & allergy
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-068717
Received 2025-11-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (5.262 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Localised pain NOS (see other SOCs for specific pain)WobblinessNot eatingAnaemia NOSElevated alanine aminotransferase (ALT)ArrhythmiaHeart murmurAbnormal radiograph findingAbnormal ultrasound findingHepatomegalyCardiac disorder NOSLiver tumour
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-067000
Received 2025-11-14 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.992 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseUnderdoseThrombocytopeniaHeart murmurHypersalivation
- Body systems
- DigestiveNeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069207
Received 2025-11-13 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (5.5 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Elevated creatine-kinase (CK)AtaxiaStiffness limbUnable to standNot eatingWeight lossLethargy (see also Central nervous system depression in Neurological)Lying downUncomfortableAbnormal cytologyIntentional misuse
- Body systems
- OtherNeurologic
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069686
Received 2025-11-12 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- Under 10 lb (3.9 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Swollen limbEpistaxisDeath by euthanasiaMalaiseHeart murmurNeutropeniaThrombocytopeniaHypoalbuminaemiaIncreased drinkingHaematuriaDecreased urine concentrationElevated protein:creatinine ratioDehydrationLymphopeniaAbdominal painIntestinal disorder NOSAbnormal radiograph findingRenal failureRenal disorder NOSInflammatory bowel disorderBronchopulmonary inflammationBruisingAnaemia NOSTachycardiaPale mucous membraneElevated alanine aminotransferase (ALT)Prolonged one stage prothrombin time (OSPT)Intentional misuseMedication error NOSPolyuriaAnorexiaAzotaemiaNecropsy performedHaemorrhage NOSFractureThyroid adenomaPancreas disorder
- Body systems
- OtherDigestive
- Outcomes
- Euthanized
USA-USFDACVM-2025-US-068543
Received 2025-11-12 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- Under 10 lb (2.948 Kilogram)
- Age
- 8+ years (16.5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Digestive tract disorder NOSGaggingTongue disorder NOSWeight lossLethargy (see also Central nervous system depression in Neurological)WobblinessGeneral illnessBlood in urineSkin lesion NOSBarberingHair loss NOSReddening of the skinVasculitis
- Body systems
- OtherNeurologicSkin & allergy
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-067403
Received 2025-11-11 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Shorthair
- Size / weight
- 10-24 lb (5.942 Kilogram)
- Age
- 8+ years (14 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- RashSkin scab
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-065825
Received 2025-11-05 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Mediumhair
- Size / weight
- Under 10 lb (3.719 Kilogram)
- Age
- 8+ years (12 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Reluctant to moveWobblinessNasal congestionSleepiness - systemic disorderHind limb paralysisThrombosisParalysisDeath by euthanasia
- Body systems
- Other
- Outcomes
- Euthanized
USA-USFDACVM-2025-US-064576
Received 2025-10-29 · MSK · MSK
- Species
- Cat
- Breed
- Domestic Longhair
- Size / weight
- 10-24 lb (7.575 Kilogram)
- Age
- 8+ years (9 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Joint swellingDistension of abdomenVomitingHaemothoraxDeath by euthanasia
- Body systems
- Skin & allergyOtherDigestive
- Outcomes
- Euthanized
USA-USFDACVM-2025-US-062909
Received 2025-10-22 · MSK · MSK
- Species
- Dog
- Breed
- Shepherd Dog - German
- Size / weight
- 100+ lb (55.792 Kilogram)
- Age
- 8+ years (9 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- VomitingShakingMedication error NOS
- Body systems
- DigestiveOther
- Outcomes
- Ongoing
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
32
Serious reports
28
Species represented
2
Grouped by Body System
Digestive (2)
· Loss of appetite, Bloody diarrhoea
Skin & allergy (4)
· Hair loss, Chewing - pruritus, Alopecia NOS
Neurologic (1)
· Unsteady walking (ataxia)
Behavior (1)
· Behavioral disorder (unspecified)
Other (24)
· Congestive heart failure, Confusion, Collapse NOS
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Neurologic | 1 | Cat | 1 | |
| Skin & allergy | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Skin & allergy | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 |
Species coverage: Cat (30) Dog (2)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Neurologic | Cat | Serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Behavior | Dog | Non-serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-069686
Source Documents
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
FDA Osteoarthritis in Cats
Official label / PI · Safety communication
Solensia Official Label (DailyMed)
Official label / PI · Official label
Solensia™
SPL · SPL
Full source previews and metadata remain in the veterinary/professional layer.
Owner handouts
0No owner handouts linked yet.
Official label / PI
2SPL
3FOI
1FDA Osteoarthritis in Cats
Official label / PI · Safety communication
This source does not expose a safe inline preview. Use the original source link for the full document.
FDA owner-facing context for osteoarthritis and Solensia in cats.
Solensia Official Label (DailyMed)
Official label / PI · Official label
This source does not expose a safe inline preview. Use the original source link for the full document.
Official Solensia label.
Solensia™
SPL · SPL
FDA Structured Product Label
Solensia™
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Zoetis Inc.
- NADA
- 141-546
- Status
- RX
- Form
- Injectable Solution
- Route
- Subcutaneous
- Species
- Cat
Composition / specifications
7 mg/mL
Label highlights
Indication
For the control of pain associated with osteoarthritis in cats.
Dosage
The full content of 1 or 2 vials based on body weight to target a minimum dosage of 0.45 mg/lb. (1 mg/kg) body weight, administered subcutaneously once a month.
Solensia SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Solensia. Use the source link for the full official labeling record.
Solensia SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Solensia. Use the source link for the full official labeling record.
FOI Summary oN 141-546 Approved January 13, 2022.pdf
FOI · FOI
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/11817 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/11898/Solensia%E2%84%A2 · document · SPL
- https://www.fda.gov/animal-veterinary/animal-health-literacy/osteoarthritis-cats-more-common-you-think · document · Safety communication
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a73b79c4-3623-4b52-81ea-6180528a031e · document · Official label
- https://www.accessdata.fda.gov/spl/data/41f60cfa-2dbc-4a75-9dff-5c29f74435cd/41f60cfa-2dbc-4a75-9dff-5c29f74435cd.xml · document · Structured Product Label
- https://www.accessdata.fda.gov/spl/data/43f946bb-0d3a-42c3-8e2d-689d829a5204/43f946bb-0d3a-42c3-8e2d-689d829a5204.xml · document · Structured Product Label
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
-
Reference facts:
Source Roxee
| Refreshed Jun 22, 2026, 10:47 AM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Jun 22, 2026, 10:40 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed May 15, 2026, 10:00 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Jun 22, 2026, 10:41 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Jun 22, 2026, 10:45 AM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
Solensia
Manufacturer mapping:
Zoetis Inc.
Case-reported brands (openFDA):
MSK
Catalog species: Both
•
FDA-labeled species: Cat
Rx/OTC: RX
Form/route:
Injectable Solution
• Subcutaneous
Applications: NADA 141-546
NDC:
Packages
54771-3520-1
54771-3520-2
•
Products
54771
Explore
Related conditions:
Osteoarthritis (Degenerative Joint Disease)
Osteoarthritis (Degenerative Joint Disease)
Pain (acute, chronic)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: M19.90
Unspecified osteoarthritis, unspecified site
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Top reaction signals
Unsteady walking (ataxia) (1)
Hair loss (1)
Congestive heart failure (1)
Confusion (1)
Collapse NOS (1)
Cold feeling to the touch (1)
Chewing - pruritus (1)
Cardiac enlargement (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
NADA: 141546
NDC Package: 54771-3520-1
NDC Package: 54771-3520-2
NDC Product: 54771
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 54771-3520-1 | 54771 | - | |
| 54771-3520-2 | 54771 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FDA Osteoarthritis in Cats
• Safety communication • Official
FDA owner-facing context for osteoarthritis and Solensia in cats.
-
Solensia Official Label (DailyMed)
• Official label • Official
Official Solensia label.
-
Solensia SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Solensia SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
FOI Summary oN 141-546 Approved January 13, 2022.pdf
• FOI summary • Official
• May 14, 2026
FDA FOI summary for application 141546
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 117
Clinical 8
Manufacturer 0
Marketing 0
Current Field Facts
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
- side_effects: Top reported reactions (openFDA): General illness, Lethargy (see also Central nervous system depression in Neurological), Prescribing error, Anorexia, Behaviou… (Clinical, 2026-04-11)
- administration: Administer by subcutaneous injection once a month, dosed by weight range, as directed and given by a veterinarian. (Official, 2026-04-22)
- approval_reference: NADA 141-546 (Official, 2026-04-22)
- brand_names: Solensia (Official, 2026-04-22)
- contraindications: Do not administer Solensia to cats with known hypersensitivity to frunevetmab. (Official, 2026-04-22)
- dosage_forms: Injection (Official, 2026-04-22)
- drug_profile_type: branded (Official, 2026-04-22)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-22)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-22)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-21)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-20)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-13)
- indications: For the control of pain associated with osteoarthritis in cats. (Official, 2026-06-12)
Recent Revisions
- monitoring updated 2026-06-22 10:47 by curated_loader • Monitoring summary based on official label adverse-reaction and administration sections.
- contraindications updated 2026-06-22 10:47 by curated_loader • Official contraindication from the Solensia label.
- prescription_required updated 2026-06-22 10:47 by curated_loader • Federal law restricts Solensia to use by or on the order of a licensed veterinarian.
- administration updated 2026-06-22 10:47 by curated_loader • Official dosage and administration directions from the Solensia label.
- strengths updated 2026-06-22 10:47 by curated_loader • Official label lists Solensia as 7 mg/mL frunevetmab injection.
- dosage_forms updated 2026-06-22 10:47 by curated_loader • Official label describes Solensia as frunevetmab injection.
- species updated 2026-06-22 10:47 by curated_loader • Official label states Solensia is for use in cats.
- usage updated 2026-06-22 10:47 by curated_loader • Official indication from the Solensia label.
- drug_profile_type updated 2026-06-22 10:47 by curated_loader • Solensia is the branded FDA-approved animal drug for frunevetmab injection.
- manufacturer_name updated 2026-06-22 10:47 by curated_loader • Official Solensia label identifies Zoetis as the labeler/manufacturer.
- brand_names updated 2026-06-22 10:47 by curated_loader • Official label identifies Solensia as the proprietary product name.
- approval_reference updated 2026-06-22 10:47 by curated_loader • Official FDA application reference for Solensia.
- monitoring updated 2026-06-22 10:07 by curated_loader • Monitoring summary based on official label adverse-reaction and administration sections.
- contraindications updated 2026-06-22 10:07 by curated_loader • Official contraindication from the Solensia label.
- prescription_required updated 2026-06-22 10:07 by curated_loader • Federal law restricts Solensia to use by or on the order of a licensed veterinarian.
- administration updated 2026-06-22 10:07 by curated_loader • Official dosage and administration directions from the Solensia label.
- strengths updated 2026-06-22 10:07 by curated_loader • Official label lists Solensia as 7 mg/mL frunevetmab injection.
- dosage_forms updated 2026-06-22 10:07 by curated_loader • Official label describes Solensia as frunevetmab injection.
- species updated 2026-06-22 10:07 by curated_loader • Official label states Solensia is for use in cats.
- usage updated 2026-06-22 10:07 by curated_loader • Official indication from the Solensia label.
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Solensia™
RX
Frunevetmab
Injectable Solution
• Subcutaneous
|
Zoetis Inc. | NADA 141-546 | Approved | May 14, 2026 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Species: Cat
Composition / specifications
7 mg/mL
Label highlights
Indication
For the control of pain associated with osteoarthritis in cats.
Dosage
The full content of 1 or 2 vials based on body weight to target a minimum dosage of 0.45 mg/lb. (1 mg/kg) body weight, administered subcutaneously once a month.
Limitations
FDA page: Open in Animal Drugs @ FDA
Usage
For the control of pain associated with osteoarthritis in cats.
Source: FDA Animal Drugs @ FDA • Reference
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Loss of appetite (1)
• Dog
Bloody diarrhoea (1)
• Cat
Showing top 5 for Digestive.
Skin & allergy
Hair loss (1)
• Cat
Chewing - pruritus (1)
• Cat
Alopecia NOS (1)
• Cat
Alopecia local (1)
• Cat
Showing top 5 for Skin & allergy.
Neurologic
Unsteady walking (1)
• Cat
Showing top 5 for Neurologic.
Behavior
Behavioral disorder (1)
• Dog
Showing top 5 for Behavior.
Other
Congestive heart failure (1)
• Cat
Confusion (1)
• Cat
Collapse NOS (1)
• Cat
Cold feeling to the touch (1)
• Cat
Cardiac enlargement (1)
• Cat
Show more (19)
Cardiac disorder NOS (1)
• Cat
Bruising (1)
• Cat
Bronchopulmonary inflammation (1)
• Cat
Breathing difficulty (1)
• Cat
Bone and joint disorder NOS (1)
• Cat
Blood in urine (1)
• Cat
Blood clot (1)
• Cat
Bladder distension (1)
• Cat
Barbering (1)
• Cat
Azotaemia (1)
• Cat
Arthritis (1)
• Cat
Arrhythmia (1)
• Cat
Anaemia NOS (1)
• Cat
Abrasion (1)
• Cat
Abnormal ultrasound finding (1)
• Cat
Abnormal radiograph finding (1)
• Cat
Abnormal movement NOS (1)
• Cat
Abnormal cytology (1)
• Cat
Abdominal pain (1)
• Cat
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Cat (other), Male • Drug: MSK, Solution, Subcutaneous • Reactions: General illness, Unable to walk • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-075364
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
Reactions Reported:
General illness
Unable to walk
Outcomes: Outcome Unknown
Cat, Domestic Longhair, Male, 8 year, 4.853 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 dose per animal • Reactions: Miliary dermatitis, Skin scab, Itching, Abnormal cytology, Pyoderma… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-075203
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Year
- Weight: 4.853 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 1 dose per animal
Reactions Reported:
Miliary dermatitis
Skin scab
Itching
Abnormal cytology
Pyoderma
Partial lack of efficacy
Skin lesion NOS
Crust
Skin sore
Outcomes: Outcome Unknown
Cat, Persian, Male, 12.5 year, 4.4 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 Vial per animal • Reactions: Intentional misuse, Lack of efficacy - NOS, Death by euthanasia, Gait abnormality, Lumbar pain • Outcome: Euthanized
- Report ID: USA-USFDACVM-2025-US-075165
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 12.50 Year
- Weight: 4.400 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 1 Vial per animal
Reactions Reported:
Intentional misuse
Lack of efficacy - NOS
Death by euthanasia
Gait abnormality
Lumbar pain
Outcomes: Euthanized
Cat, Cat (other), Female, 12 year • Drug: MSK, Solution, Subcutaneous • Reactions: Congestive heart failure, Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-075411
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 12.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
Reactions Reported:
Congestive heart failure
Death
Outcomes: Died
Cat, Domestic Shorthair, Male, 14 year, 9.072 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 14 Milligram per animal • Reactions: Vomiting, Hiding, Dazed, Heavy breathing, Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-075300
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 14.00 Year
- Weight: 9.072 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 14 Milligram per animal
Reactions Reported:
Vomiting
Hiding
Dazed
Heavy breathing
Death
Outcomes: Died
Cat, Domestic Mediumhair, Male, 15 year, 7.711 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 14 Milligram per animal • Reactions: Dermatitis, Hyperpigmentation • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-075219
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 15.00 Year
- Weight: 7.711 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 14 Milligram per animal
Reactions Reported:
Dermatitis
Hyperpigmentation
Outcomes: Ongoing
Cat, Domestic Shorthair, Female, 11 year, 4.754 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 1 Vial per animal, Frequency: 1 per month • Reactions: Miliary dermatitis, Excoriation • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-075455
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 11.00 Year
- Weight: 4.754 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Solution
- Dose: 1 Vial per animal
- Frequency: 1 per month
Reactions Reported:
Miliary dermatitis
Excoriation
Outcomes: Ongoing
Cat, Domestic Shorthair, Male, 13 year, 6.876 kilogram • Drug: MSK, Injection, solution, Subcutaneous, Dose: 7 Milligram per animal • Reactions: Fever, Not eating, Neutrophilia, Monocytosis, Immune mediated haemolytic anaemia… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-074332
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 13.00 Year
- Weight: 6.876 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection, solution
- Dose: 7 Milligram per animal
Reactions Reported:
Fever
Not eating
Neutrophilia
Monocytosis
Immune mediated haemolytic anaemia
Behavioral disorder (unspecified)
Decreased haematocrit
Outcomes: Ongoing
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.